Navigation Links
Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
Date:1/31/2008

ased 12%, including a 3% favorable foreign exchange impact, to $19.3 billion compared to the same period in 2006. Net earnings from continuing operations in the twelve months of 2007 on a GAAP basis were $2.0 billion, or $0.99 per diluted share, compared to $1.4 billion, or $0.73 per diluted share for the same period last year. On a non-GAAP basis, excluding specified items, Bristol-Myers Squibb reported net earnings from continuing operations of $2.7 billion, or $1.38 per diluted share for the twelve months ended December 31, 2007, compared to $2.0 billion, or $1.01 per diluted share for the same period last year. Included in discontinued operations were Medical Imaging full year 2007 and 2006 net sales of $629 million and $658 million, respectively, and basic and diluted earnings per share of $0.10 and $0.08 in 2007 and 2006, respectively.

NEW PRODUCT AND PIPELINE DEVELOPMENTS

In December, the European Commission granted marketing authorization for ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), formally approving ATRIPLA(R) for commercialization in the 27 countries of the European Union, as well as in Norway and Iceland. ATRIPLA(R) has been launched in the United Kingdom, Germany and Austria.

In December, Bristol-Myers Squibb and Medarex, Inc. announced top-line data from three registrational trials that constitute the monotherapy program for ipilimumab in patients with metastatic melanoma. The companies plan to meet with regulatory agencies in the near future to discuss possible regulatory pathways forward based on these data.

In November, Bristol-Myers Squibb and Pierre Fabre Medicament announced the termination of the license agreement for the development of vinflunine, a chemotherapy agent under investigation for the treatment of advanced or metastatic bladder cancer and other tumor types.

In November, ABILIFY(R) (aripiprazole) was approved by the Food and Drug Administration (FDA) as
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related medicine news :

1. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
2. Bristol-Myers Squibb Names Alan J. Lacy to Board of Directors
3. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
4. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
5. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
6. Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
7. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
8. Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing
9. Bristol-Myers Squibb Announces Dividend
10. P&G Reports $0.98 EPS, Up 17%, on 9% Sales Growth; Announces Plan to Create Stand-Alone Coffee Company
11. First Pharmaceutical Company Comes to Hoboken, NJ: Swiss-Based Octapharma to Move U.S. Headquarters to SJP Properties Waterfront Corporate Center II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Dallas, Texas (PRWEB) May 21, 2013 ... growth. Its expanding national presence has required the hiring ... , HealthSmart is pleased to announce that Dawn ... She is serving as the Director of Account Management ... HealthSmart Corporate offices in Irving, Texas. With extensive client ...
(Date:5/21/2013)... According to a May 13, 2013 New ... Botox,” Botox injections have become the most popular ... (Go to goo.gl/8iYbD). Although it is mostly associated with women, ... injection makes facial wrinkles less visible by paralyzing facial muscles. ... three months. This means that people who are conscious about ...
(Date:5/21/2013)... May 21, 2013 Global Proving Ground ... Bodybuilding.com, the largest online retailer of health and fitness ... reality-based sports show, Warrior Island. “We cast the ... Facebook & Twitter, with our unique social networking platform,” ... these elite fighters on an island in the Pacific ...
(Date:5/21/2013)... genetic features of pulmonary fibrosis by physicians and scientists ... lead to improved treatment of this deadly lung disease, ... . , The study found that a particular genetic ... fibrosis, a chronic progressive disease with a median survival ... researchers may want to consider including genetic testing in ...
(Date:5/21/2013)... May 21, 2013 The Las Vegas personal ... to announce that Crawford Gates, a senior at Coronado High ... college scholarship essay contest . As the winner of the ... essay contest started on Dec. 1, 2012 and ran through ... to submit a three-page minimum essay on “The Role of ...
Breaking Medicine News(10 mins):Health News:New Talent Joins the HealthSmart Account Management Team 2Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2
... 21 Talk About Curing Autism (TACA) is ... grant from the Newport Beach based Pacific Life Foundation. ... TACA will launch three new programs for Orange County, ... an in house advocate to provide education, training and ...
... Attorneys for The American Legion Department of Indiana have ... study cited by the Indiana State Department of Health ... the Indiana Soldiers, and Sailors, Children,s Home at Knightstown, ... Indiana,s Public Records Act, which requires the Department to ...
... linked to wind pattern that controls winter in Northern Hemisphere ... that flower buds are popping open earlier in the spring, ... , Not only have average worldwide temperatures been rising for ... year has shifted almost two days earlier. , That,s ...
... Jan. 21, 2009 Joslin Diabetes Center scientists are ... 2 diabetes to a new level with the launch of ... drug used for years to manage arthritis pain, can reduce ... successful, the trial could lead one day to an inexpensive ...
... ProvidersDALLAS, Jan. 21 Claimsnet.com (OTC ... MedAvant Healthcare Solutions (MedAvant) to provide a private ... MedAvant, we will be able to help our ... flow--a must in today,s market of tightening margins," ...
... popularity, it is critical for physicians to understand potential risks ... Company, the largest national insurer of physician and surgeon medical ... physicians successfully navigate telemedicine liability risks. , ... ...
Cached Medicine News:Health News:Talk About Curing Autism Receives $300,000 Grant From Pacific Life Foundation to Provide Services for Families Affected by Autism in Orange County 2Health News:Legion Attorneys Seek Copy of Health Department Study on Children's Home 2Health News:Seasons Arriving 2 Days Earlier, Study Says 2Health News:Joslin launches national study to explore if anti-inflammatory drug can treat type 2 diabetes 2Health News:Joslin launches national study to explore if anti-inflammatory drug can treat type 2 diabetes 3Health News:MedAvant and Claimsnet Form Strategic Partnership 2Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 2Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 3Health News:The Doctors Company Provides Tips for Physicians to Minimize Risk While Practicing Medicine by Phone or E-mail 4
(Date:5/21/2013)... May 21, 2013  IsoRay, Inc. (AMEX: ... has entered into an exclusive international distribution agreement with ... line in Greece . IsoRay is ... and medical radioisotope applications for brain cancer, lung cancer, ... cancer. IASIS Medical is ideally suited ...
(Date:5/21/2013)... Hurel Corporation ("Hurel"), a world-leading provider of ... today announced the appointment of James S. ... of Directors. Dr. MacDonald is the former Executive Vice ... ("SPRI"), which was the pharmaceutical development arm of Schering ... in 2009. Over a career that has ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said.  "While the old classification of ...
Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... N.J., Oct. 12 PharmaNet Development Group, Inc., ... innovative pharmaceutical, biotechnology, generic drug and medical device ... subsidiaries Anapharm and Taylor Technology will be showcasing ... AAPS Annual Meeting and Exposition. , Taylor ...
... Schering-Plough Corporation (NYSE: SGP ) is scheduled to ... quarter on Thursday, Oct. 22, 2009. , At ... a conference call to review results for the 2009 third ... members of management will host the conference call. , ...
Cached Medicine Technology:PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009 2PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009 3PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009 4Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: